Skip to main content
OpenTrials
Completed

NCT Number: NCT03998007

Development of a Medical Device Utilizing an EEG-Based Algorithm for the Objective Quantification of Pain

Obtained 19 lead EEG data from 50 chronic pain patients along with their clinical history and self-reported pain scored. Machine learning was used to analyze the EEG data and derive a chronic pain biomarker.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Boston Pain Care Center

Waltham, Massachusetts, 02451, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male and female chronic pain patients
  • Patients between the ages of 18-85 years
  • Patients exhibiting the presence of symptoms in excess of 3 months duration
  • Patients suffering from neuropathic (e.g., lower back pain), osteoarthritis, or muscular skeletal pain
  • Patients with evidence of pathology related to the painful condition on which diagnosis was made (e.g., results of imaging or diagnostic pain code)
  • Patients with NRS pain scores across the full range (1-10) at the time of testing

Exclusion criteria

  • Patients with medically diagnosed psychotic illness
  • Patients with medically diagnosed drug or alcohol dependence in the past 12 months
  • Patients with a medical history of head injury with loss of consciousness and amnesia (within the last 2 years)
  • Patients with skull abnormalities that preclude the proper placement of the electrodes for the EEG data acquisition
  • Patients who have a spinal cord stimulator, or other implantable devices
  • Patients for whom the source of pain at the time of the evaluation is associated with: neurological disorders (multiple sclerosis, Parkinson, dementia), diabetes, migraines, or those with reflex / sympathetic dystrophy disorder/complex regional pain syndrome, fibromyalgia, or visceral pain
  • Patients with cancer
  • Patients on workers compensation or disability
  • Patient on anticonvulsant medication
  • Patients who have a history of seizures

Treatment and study plan

IRIS System

Device

A QEEG based pain biomarker that scales with the patient reported NRS

Primary outcomes

  1. Pearsons Correlation between IRIS derived pain biomarker and patient reported Numeric Rating Scale (0-10)

    Time frame: 6 Months

    A Pearson Correlation of 1.0 is perfection correlation and 0 no correlation between the two measured variables

Sponsors and collaborators

Lead sponsor

PainQx, Inc

Industry

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Jun 25, 2019
Registry last updated
Jun 27, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.